sv3
As filed with the Securities and Exchange Commission on January 14, 2010
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
HOME BANCSHARES, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Arkansas
(State or other jurisdiction of
incorporation or organization)
|
|
71-0682831
(IRS Employer
Identification Number) |
719 Harkrider, Suite 100
Conway, Arkansas 72032
(501) 328-4770
(Address including zip code, and telephone number,
including area code, of registrants principal executive offices)
C. Randall Sims
Chief Executive Officer
Home BancShares, Inc.
719 Harkrider
Conway, Arkansas 72032
(501) 328-4656
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copies to:
C. Douglas Buford, Jr., Esq.
Mitchell, Williams, Selig, Gates & Woodyard, P.L.L.C.
425 West Capitol Avenue, Suite 1800
Little Rock, Arkansas 72201
Telephone: (501) 688-8866
Facsimile: (501) 918-7866
Approximate date of commencement of proposed sale to the public: From time to time after the
effective date of this Registration Statement.
If the only securities being registered on this Form are being offered pursuant to dividend or
interest reinvestment plans, please check the following box. o
If any of the securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. þ
If this Form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. o
If this Form is a registration statement pursuant to General Instruction I.D. or a
post-effective amendment thereto that shall become effective upon filing with the Commission
pursuant to Rule 462(e) under the Securities Act, check the following box. o
If this Form is a post-effective amendment to a registration statement filed pursuant to
General Instruction I.D. filed to register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities Act, check the following box. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer þ
|
|
Non-accelerated filer o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company o |
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum |
|
|
Proposed Maximum |
|
|
|
|
|
Title of Each Class of |
|
|
Amount to be |
|
|
Offering Price Per |
|
|
Aggregate Offering |
|
|
Amount of |
|
|
Securities to be Registered |
|
|
Registered (1)(2) |
|
|
Security (1)(2) |
|
|
Price (1)(2) |
|
|
Registration Fee (3) |
|
|
Common Stock, par value $0.01 per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, par value $0.01 per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
200,000,000 |
|
|
|
$ |
14,260 |
|
|
|
|
|
|
(1) |
|
Not specified as to each class of securities to be registered pursuant to General Instruction II.D of Form S-3. |
|
(2) |
|
An indeterminate aggregate initial offering price or number of securities of each identified class is being registered as may be issued at
indeterminate prices from time to time. The securities registered include unspecified amounts and numbers of securities that may be
issued upon conversion of or exchange for securities that provide for conversion or exchange or pursuant to the antidilution provisions of
any such securities. Separate consideration may or may not be received for securities issuable on exercise, conversion, or exchange of
other securities. |
|
(3) |
|
Calculated in accordance with Rule 457(o) under the Securities Act. |
The registrant hereby amends this registration statement on such date or dates as may be necessary
to delay its effective date until the registrant shall file a further amendment which specifically
states that this registration statement shall thereafter become effective in accordance with
Section 8(a) of the Securities Act of 1933 or until the registration statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
The information in this prospectus is not complete and may be changed.
This prospectus is included in a registration statement that we filed with the
Securities and Exchange Commission. We may not sell these securities or accept
an offer to buy these securities until the registration statement filed with
the Securities and Exchange Commission is effective. This prospectus is not an
offer to sell these securities, and it is not soliciting offers to buy these
securities in any state where such offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED JANUARY 14, 2010
PROSPECTUS
HOME BANCSHARES, INC.
Common Stock
Preferred Stock
Rights
Warrants
We may offer and sell, from time to time, in one or more offerings, any combination of debt
and equity securities that we describe in this prospectus having a total initial offering price not
exceeding $200,000,000.
This prospectus provides you with a general description of these securities. We will file
prospectus supplements and may provide other offering material at later dates that will contain
specific terms of each issuance of securities. These supplements may also add, update or change
information contained in this prospectus.
You should read this prospectus and the applicable prospectus supplement carefully before you
invest in the securities described in the applicable prospectus supplement. This prospectus may
not be used to consummate sales of securities unless accompanied by a prospectus supplement.
Our common stock is listed on the NASDAQ Global Select Market under the symbol HOMB.
Investing in our securities involves a high degree of risk. See the section entitled Risk
Factors on page 5 of this prospectus and in the documents we filed with the Securities and
Exchange Commission that are incorporated in this prospectus by reference for certain risks and
uncertainties you should consider.
Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or passed upon the adequacy of this prospectus. Any
representation to the contrary is a criminal offense in the United States.
These securities are unsecured and are not deposits and are not insured by the Federal Deposit
Insurance Corporation or any other governmental agency.
This prospectus is dated January 14, 2010.
TABLE OF CONTENTS
January 14, 2010
2
ABOUT THIS PROSPECTUS
This prospectus is a part of a registration statement on Form S-3 that we filed with the
Securities and Exchange Commission (SEC) utilizing a shelf registration process. Under this
shelf registration process, we may, from time to time, sell the securities described in this
prospectus in one or more offerings.
The registration statement containing this prospectus, including the exhibits to the
registration statement, provides additional information about us and the securities offered under
this prospectus. The registration statement, including the exhibits and the documents incorporated
herein by reference, can be read on the SEC website or at the SEC offices mentioned under the
heading Where You Can Find More Information.
We may provide a prospectus supplement containing specific information about the amounts,
prices and terms of the securities for a particular offering. The prospectus supplement may add,
update or change information in this prospectus. If the information in the prospectus is
inconsistent with a prospectus supplement, you should rely on the information in that prospectus
supplement. You should read both this prospectus and, if applicable, any prospectus supplement.
See Where You Can Find More Information for more information.
We have not authorized any dealer, salesman or other person to give any information or to make
any representation other than those contained or incorporated by reference in this prospectus or
any prospectus supplement. You must not rely upon any information or representation not contained
or incorporated by reference in this prospectus or any prospectus supplement. This prospectus and
any prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy
any securities other than the registered securities to which they relate, nor do this prospectus
and any prospectus supplement constitute an offer to sell or the solicitation of an offer to buy
securities in any jurisdiction to any person to whom it is unlawful to make such offer or
solicitation in such jurisdiction. You should not assume that the information contained in this
prospectus or any prospectus supplement is accurate on any date subsequent to the date set forth on
the front of such document or that any information we have incorporated by reference is correct on
any date subsequent to the date of the document incorporated by reference, even though this
prospectus and any prospectus supplement is delivered or securities are sold on a later date.
Unless otherwise stated or the context otherwise requires, all references to Home
BancShares, the Company, we, our, us and similar terms refer to Home BancShares, Inc. and
its consolidated subsidiaries, unless the context requires otherwise.
Unless otherwise indicated, currency amounts in this prospectus and in any applicable
prospectus supplement are stated in U.S. dollars.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Some of our statements contained in this document are forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of
1934, as amended (the Exchange Act). Forward-looking statements relate to future events or our
future financial performance and include statements about the competitiveness of the banking
industry, potential regulatory obligations, our entrance and expansion into other markets, our
other business strategies and other statements that are not historical facts. Forward-looking
statements are not guarantees of performance or results. When we use words like may, plan,
contemplate, anticipate, believe, intend, continue, expect, project, predict,
estimate, could, should, would, and similar expressions, you should consider them as
identifying forward-looking statements, although we may use other phrasing. These forward-looking
statements involve risks and uncertainties and are based on our beliefs and assumptions, and on the
information available to us at the time that these disclosures were prepared. These
forward-looking statements involve risks and uncertainties and may not be realized due to a variety
of factors, including, but not limited to, the following:
|
|
|
the effects of future economic conditions, including inflation or a decrease in
residential housing values; |
|
|
|
|
governmental monetary and fiscal policies, as well as legislative and regulatory
changes; |
|
|
|
|
the risks of changes in interest rates or the level and composition of deposits,
loan demand and the values of loan collateral, securities and interest sensitive assets
and liabilities; |
3
|
|
|
the effects of terrorism and efforts to combat it; |
|
|
|
|
credit risks; |
|
|
|
|
the effects of competition from other commercial banks, thrifts, mortgage banking
firms, consumer finance companies, credit unions, securities brokerage firms, insurance
companies, money market and other mutual funds and other financial institutions
operating in our market area and elsewhere, including institutions operating
regionally, nationally and internationally, together with competitors offering banking
products and services by mail, telephone and the Internet; |
|
|
|
|
the effect of any mergers, acquisitions or other transactions to which we or our
subsidiaries may from time to time be a party, including our ability to successfully
integrate any businesses that we acquire; and |
|
|
|
|
the failure of assumptions underlying the establishment of our allowance for loan
losses. |
All written or oral forward-looking statements attributable to us are expressly qualified in
their entirety by this Cautionary Note. Our actual results may differ significantly from those we
discuss in these forward-looking statements. For other factors, risks and uncertainties that could
cause our actual results to differ materially from estimates and projections contained in these
forward-looking statements, see the Risk Factors section provided below.
WHERE YOU CAN FIND MORE INFORMATION
We are subject to the information requirements of the Exchange Act. Accordingly, we file
annual, quarterly and current reports, proxy statements and other information with the SEC and
filed a registration statement on Form S-3 under the Securities Act relating to the securities
offered by this prospectus. This prospectus, which forms part of the registration statement, does
not contain all of the information included in the registration statement. For further
information, you should refer to the registration statement and its exhibits.
You may read and copy the registration statement and any document we file with the SEC at the
SECs Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330 for further information on the operation of the Public Reference Room. You can also
review our filings by accessing the website maintained by the SEC at http://www.sec.gov. The site
contains reports, proxy and information statements and other information regarding issuers that
file electronically with the SEC. In addition to the foregoing, we maintain a website at
http://www.homebancshares.com. Our website content is made available for informational purposes
only. It should neither be relied upon for investment purposes nor is it incorporated by reference
into this prospectus. We make available on our internet website copies of our Annual Reports on
Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to such
document as soon as practicable after we electronically file such material with or furnish such
documents to the SEC.
DOCUMENTS INCORPORATED BY REFERENCE
The SEC allows us to incorporate by reference information that we file with the SEC into
this prospectus, which means we can disclose important information to you by referring you to
another document. The information incorporated by reference is considered to be part of this
prospectus from the date on which we file that document. Any reports filed by us with the SEC after
the date of this prospectus and before the termination of the offering of the securities by means
of this prospectus will automatically update and, where applicable, supersede information contained
in this prospectus or incorporated by reference into this prospectus. We incorporate by reference
the following documents listed below and any future filings made with the SEC under Sections 13(a),
13(c), 14 or 15(d) of the Exchange Act, until the termination of the offering of the securities
offered hereby:
(a) Our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, filed with the
Commission on March 6, 2009.
(b) Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, filed with the
Commission on May 6, 2009, and amended on May 7, 2009, and our Quarterly Reports on Form 10-Q for
the quarters ended June 30, 2009, and September 30, 2009, filed with the Commission on August 5,
2009, and November 3, 2009, respectively.
4
(c) Our Current Reports on Form 8-K, filed with the Commission on January 9, 2009, January 15,
2009, January 21, 2009, March 13, 2009, April 7, 2009, April 23, 2009, July 16, 2009, July 17,
2009, July 20, 2009, September 11, 2009, September 16, 2009, September 21, 2009, October 7, 2009,
and October 15, 2009, respectively.
(d) The description of our Common Stock contained in our Registration Statement on Form 10,
filed under Section 12 of the Exchange Act, and all amendments or reports filed for the purpose of
updating such description.
You may request a copy of these filings, at no cost, by writing or calling us at the following
address:
Home BancShares, Inc.
719 Harkrider, Suite 100
Conway, Arkansas 72032
Attn: Corporate Secretary
(501) 328-4770
THE COMPANY
We are a Conway, Arkansas headquartered bank holding company registered under the federal Bank
Holding Company Act of 1956. Through our wholly owned community bank subsidiary Centennial Bank
we provide a full range of banking services to individual and corporate customers in central
Arkansas, north central Arkansas, southern Arkansas, the Florida Keys and southwestern Florida.
In 1998, an investor group led by John W. Allison, our Chairman, and Robert H. Bunny Adcock,
Jr., our Vice Chairman, formed Home BancShares, Inc. We established First State Bank in Conway,
Arkansas, in 1999, and subsequently acquired and integrated banks in Cabot, Little Rock, North
Little Rock and Mountain View, Arkansas, and in Marathon, Florida.
We recently combined the charters of our subsidiary banks into a single charter and adopted
Centennial Bank as the common name. All of our banks now have the same name, logo and charter,
allowing for a more customer-friendly banking experience and seamless transactions across our
entire banking network. We remain committed, however, to our community banking philosophy and will
continue to rely on local community bank boards and management built around experienced bankers
with strong local relationships.
Our principal executive office is located at 719 Harkrider, Suite 100, Conway, Arkansas, and
our telephone number is (501) 328-4770.
RISK FACTORS
An investment in our securities involves significant risks. Our business, financial
condition, and results of operations could be materially adversely affected by any of these risks.
The trading price of our securities could decline due to any of these risks, and you may lose all
or part of your investment. Before you make an investment decision regarding the securities, you
should carefully consider the risks and uncertainties described under Risk Factors in the
applicable prospectus supplement and in our most recent Annual Report on Form 10-K, and in any
updates to those Risk Factors in our Quarterly Reports on Form 10-Q, together with all of the other
information appearing in this prospectus or incorporated by reference into this prospectus and any
applicable prospectus supplement, in light of your particular investment objectives and financial
circumstances. The risks described in those documents are not the only ones that we face.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial
may also affect our business operations, our financial results and the value of the securities.
The prospectus supplement applicable to each series of securities we offer may contain a discussion
of additional risks applicable to an investment in us and the securities we are offering under that
prospectus supplement.
5
USE OF PROCEEDS
Unless otherwise specified in the applicable prospectus supplement, we intend to use the
proceeds from the sale of the securities described in this prospectus for general corporate
purposes and to support our ongoing and future anticipated growth, including potential
acquisitions. Pending such use, we may temporarily invest the proceeds or use them to reduce
indebtedness. The applicable prospectus supplement will provide more details on the use of
proceeds of any specific offering.
RATIOS OF EARNINGS TO FIXED CHARGES AND PREFERRED SHARE DIVIDENDS
The following table sets forth our consolidated ratios of earnings to combined fixed charges
and preferred share dividends for the periods shown. For purposes of computing the ratios,
earnings represent the sum of income from continuing operations before taxes plus fixed charges and
preferred share dividend requirements. Fixed charges represent total interest expense, including
and excluding interest on deposits. Preferred share dividend requirements represent the amount of
pre-tax income required to pay the dividends on preferred shares. Before we issued the Series A
Preferred Shares, as defined below, on January 16, 2009, we had no preferred shares outstanding
since August 1, 2006 and had not paid any dividends on preferred shares since 2006. See
DESCRIPTION OF CAPITAL STOCK General. Therefore, the ratio of earnings to combined fixed
charges and preferred share dividends is not different from the ratio of earnings to fixed charges
for the years ended December 31, 2007 and 2008, and the nine months ended September 30, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
September 30, |
|
|
Years Ended December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
2008 |
|
|
2007 |
|
|
2006 |
|
|
2005 |
|
|
2004 |
|
Ratio of Earnings to Fixed Charges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Including interest on deposits |
|
|
1.93 |
x |
|
|
1.61 |
x |
|
|
1.20 |
x |
|
|
1.39 |
x |
|
|
1.38 |
x |
|
|
1.47 |
x |
|
|
2.31 |
x |
Excluding interest on deposits |
|
|
4.01 |
x |
|
|
3.63 |
x |
|
|
1.84 |
x |
|
|
2.62 |
x |
|
|
2.57 |
x |
|
|
2.82 |
x |
|
|
4.74 |
x |
Ratio of Earnings to Fixed Charges and
Preferred Dividends: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Including interest on deposits |
|
|
1.83 |
x |
|
|
1.61 |
x |
|
|
1.20 |
x |
|
|
1.39 |
x |
|
|
1.38 |
x |
|
|
1.45 |
x |
|
|
2.21 |
x |
Excluding interest on deposits |
|
|
3.39 |
x |
|
|
3.63 |
x |
|
|
1.84 |
x |
|
|
2.62 |
x |
|
|
2.51 |
x |
|
|
2.65 |
x |
|
|
4.20 |
x |
DESCRIPTION OF SECURITIES WE MAY OFFER
This prospectus contains summary descriptions of our common stock, preferred stock, rights and
warrants that we may offer from time to time. These summary descriptions are not meant to be
complete descriptions of each security. The particular terms of any security will be described in
the accompanying prospectus supplement and other offering material. The accompanying prospectus
supplement may add, update or change the terms and conditions of the securities as described in
this prospectus.
When we use the terms security or securities in this prospectus, we mean any of the
securities we may offer with this prospectus, unless we say otherwise. The total dollar amount of
all securities that we may issue pursuant to this prospectus will not exceed $200,000,000.
DESCRIPTION OF CAPITAL STOCK
The following is a description of our common stock and certain provisions of our Articles of
Incorporation, Bylaws and certain provisions of applicable law. The following is only a summary
and is qualified by applicable law and by the provisions of our Articles of Incorporation and
Bylaws, copies of which have been filed with the SEC and are also available upon request from us.
6
General
Under our Articles of Incorporation, as amended, we have authority to issue up to 50,000,000
shares of common stock, par value $0.01 per share, and up to 5,500,000 shares of preferred stock,
par value $0.01 per share. Each share of our common stock has the same relative rights as, and is
identical in all respects to, each other share of our common stock.
As of December 31, 2009, 25,690,137 shares of our common stock were issued and outstanding,
and 1,275,541 shares of common stock were reserved for issuance pursuant to the Companys stock
option plan. Our common stock is listed on the NASDAQ Global Select Market. The outstanding
shares of our common stock are validly issued, fully paid and non-assessable.
As of December 31, 2009, 50,000 shares of our preferred stock are issued and outstanding, all
of which have been designated as Fixed Rate Cumulative Perpetual Preferred Stock, Series A, par
value $0.01 per share (the Series A Preferred Shares). All of the Series A Preferred Shares were
issued to the United States Department of the Treasury (the Treasury) on January 16, 2009, in a
transaction exempt from the registration requirements of the Securities Act pursuant to the
Treasurys Capital Purchase Program. As required by the Treasury, we subsequently registered the
Series A Preferred Shares on a Form S-3 registration statement (File No. 333-157165), filed with
the Commission on February 6, 2009.
Common Stock
Voting Rights. Holders of our common stock are entitled to one vote per share on all matters
submitted to a vote of shareholders. Holders of our common stock do not have cumulative voting
rights.
Dividend Rights. Holders of our common stock are entitled to dividends when, as, and if
declared by our board of directors out of funds legally available for the payment of dividends.
Holders of Series A Preferred Shares have (and other series of preferred stock may in the future
have) a priority over holders of common stock with respect to dividends.
Until the earlier of January 16, 2012 or the date on which the Treasury no longer holds any of
our Series A Preferred Shares, we may not declare or pay any dividend or make any distribution on
the common stock, other than regular quarterly cash dividends of not more than $0.06 per share, as
adjusted for any stock split, stock dividend, reverse stock split, reclassification or similar
transaction; dividends payable solely in common stock; and dividends or distributions of rights or
junior shares in connection with a shareholders rights plan.
Liquidation and Dissolution. In the event of the liquidation, dissolution and winding up of
the Company, the holders of our common stock are entitled to receive ratably all of the assets of
the Company available for distribution after satisfaction of all liabilities of the Company,
subject to the rights of the holders of any of the Companys preferred shares that may be issued
from time to time.
Other Rights. Holders of our common stock have no preferential or preemptive rights with
respect to any securities of Home BancShares, and there are no conversion rights or redemption or
sinking fund provisions applicable to our common stock.
Restrictions on Ownership. The Bank Holding Company Act requires any bank holding company,
as defined in the Bank Holding Company Act, to obtain the approval of the Federal Reserve Board
prior to the acquisition of 5% or more of our common stock. Any person, other than a bank holding
company, is required to obtain prior approval of the Federal Reserve Board to acquire 10% or more
of our common stock under the Change in Bank Control Act. Any holder of 25% or more of our common
stock, or a holder of 5% or more if such holder otherwise exercises a controlling influence over
us, is subject to regulation as a bank holding company under the Bank Holding Company Act.
Modification of Rights. Rights of the holders of our common stock may not be modified by less
than a majority vote of the common stock outstanding. Additionally, under the Arkansas Business
Corporation Act of 1987, a majority vote is required for the approval of a merger or consolidation
with another corporation, and for the sale of all or substantially all of our assets and
liquidation or dissolution of Home BancShares.
7
Transfer Agent. The transfer agent and registrar for our common stock is Computershare
Investor Services, P.O. Box 43078, Providence, Rhode Island 02940-3078.
Preferred Stock
The 5,450,000 unissued shares of our preferred stock, par value $0.01 per share, are typically
referred to as blank check preferred stock. This term means that these shares of preferred stock
may be issued with such preferences, limitations, relative rights, and terms as determined by our
board of directors. As such, the board of directors can, without shareholder approval, issue
preferred stock with voting, dividend, liquidation and conversion rights that could dilute the
voting strength of the holders of the common stock and may assist management in impeding an
unfriendly takeover or attempted change in control.
The terms of any particular series of preferred stock will be described in the prospectus
supplement relating to that particular series of preferred stock.
DESCRIPTION OF RIGHTS
In this section, we describe the general terms and provisions of the rights to securities that
we may offer to our shareholders. Rights may be issued independently or together with any other
offered security and may or may not be transferable by the person purchasing or receiving the
rights. In connection with any rights offering to our shareholders, we may enter into a standby
underwriting or other arrangement with one or more underwriters or other persons pursuant to which
such underwriters or other person would purchase any offered securities remaining unsubscribed for
after such rights offering. Each series of rights will be issued under a separate rights agent
agreement to be entered into between us and a bank or trust company, as rights agent, that we will
name in the applicable prospectus supplement. The rights agent will act solely as our agent in
connection with the certificates relating to the rights of the series of certificates and will not
assume any obligation or relationship of agency or trust for or with any holders of rights
certificates or beneficial owners of rights.
The prospectus supplement relating to any rights we offer will include specific terms relating
to the offering, including, among others, the date of determining the shareholders entitled to the
rights distribution, the aggregate number of rights issued and the aggregate amount of securities
purchasable upon exercise of the rights, the exercise price, the conditions to completion of the
offering, the date on which the right to exercise the rights will commence and the date on which
the right will expire, and any applicable U.S. federal income tax considerations. To the extent
that any particular terms of the rights, rights agent agreements, or rights certificates described
in a prospectus supplement differ from any of the terms described here, then the terms described
here will be deemed to have been superseded by that prospectus supplement.
Each right would entitle the holder of the rights to purchase for cash the principal amount of
securities at the exercise price set forth in the applicable prospectus supplement. Rights may be
exercised at any time up to the close of business on the expiration date for the rights provided in
the applicable prospectus supplement. After the close of business on the expiration date, all
unexercised rights would become void and of no further force or effect.
Holders may exercise rights as described in the applicable prospectus supplement. Upon
receipt of payment and the rights certificate properly completed and duly executed at the corporate
trust office of the rights agent or any other office indicated in the prospectus supplement, we
will, as soon as practicable, forward the securities purchasable upon exercise of the rights. If
less than all of the rights issued in any rights offering are exercised, we may offer any
unsubscribed securities directly to persons other than shareholders, to or through agents,
underwriters or dealers or through a combination of such methods, including pursuant to standby
arrangements, as described in the applicable prospectus supplement.
The description in the applicable prospectus supplement and other offering material of any
rights we offer will not necessarily be complete and will be qualified in its entirety by reference
to the applicable rights agent agreement, which will be filed with the SEC if we offer rights. For
more information on how you can obtain copies of the applicable rights agent agreement if we offer
rights, see Documents Incorporated by Reference and Where You Can Find More Information. We
urge you to read the applicable rights agent agreement and the applicable prospectus supplement and
any other offering material in their entirety.
8
DESCRIPTION OF WARRANTS
We may issue warrants from time to time in one or more series for the purchase of our common
stock or preferred stock or any combination of those securities. Warrants may be issued
independently or together with any shares of common stock or shares of preferred stock or offered
by any prospectus supplement and may be attached to or separate from common stock or preferred
stock. Each series of warrants will be issued under a separate warrant agreement to be entered
into between us and a warrant agent, or any other bank or trust company specified in the related
prospectus supplement relating to the particular issue of warrants. The warrant agent will act as
our agent in connection with the warrants and will not assume any obligation or relationship of
agency or trust for or with any holders of warrants or beneficial owners of warrants. The specific
terms of a series of warrants will be described in the applicable prospectus supplement relating to
that series of warrants along with any general provisions applicable to that series of warrants.
The following is a general description of the warrants we may issue. The applicable
prospectus supplement will describe the specific terms of any issuance of warrants. The terms of
any warrants we offer may differ from the terms described in this prospectus. As a result, we will
describe in the prospectus supplement the specific terms of the particular series of warrants
offered by that prospectus supplement. Accordingly, for a description of the terms of a particular
series of warrants, you should carefully read this prospectus, the applicable prospectus
supplement, and the applicable warrant agreement, which will be filed as an exhibit to the
registration statement of which this prospectus forms a part.
Terms. If warrants are offered by us, the prospectus supplement will describe the terms of
the warrants, including the following if applicable to the particular offering:
|
|
|
the title of the warrants; |
|
|
|
|
the total number of warrants; |
|
|
|
|
the number of shares of common stock purchasable upon exercise of the warrants to
purchase common stock and the price at which such shares of common stock may be purchased
upon exercise; |
|
|
|
|
the designation and terms of the preferred stock with which the warrants are issued and
the number of warrants issued with each share of preferred stock; |
|
|
|
|
the date on and after which the warrants and the related common stock or preferred stock
will be separately transferable; |
|
|
|
|
if applicable, the date on which the right to exercise the warrants will commence and
the date on which this right will expire; |
|
|
|
|
if applicable, the minimum or maximum amount of the warrants which may be exercised at
any one time; |
|
|
|
|
a discussion of federal income tax, accounting and other special considerations,
procedures and limitations relating to the warrants; and |
|
|
|
|
any other terms of the warrants including terms, procedures and limitations relating to
the exchange and exercise of the warrants. |
Warrants may be exchanged for new warrants of different denominations, may be presented for
registration of transfer, and may be exercised at the office of the warrant agent or any other
office indicated in the prospectus supplement. Before the exercise of their warrants, holders of
warrants will not have any of the rights of holders of shares of common stock or shares of
preferred stock purchasable upon exercise, including the right to receive payments of dividends, if
any, on the shares common stock or preferred stock purchasable upon such exercise or to exercise
any applicable right to vote.
Exercise of Warrants. Each warrant will entitle the holder to purchase a number of shares of
common stock or shares of preferred stock at an exercise price as will in each case be set forth
in, or calculable from, the prospectus supplement relating to those warrants. Warrants may be
exercised at the times set forth in the prospectus supplement relating to the warrants. After the
close of business on the expiration date (or any later date to which the expiration date may be
extended by us), unexercised warrants will become void. Subject to any restrictions and additional
requirements that may be set forth in the prospectus supplement relating thereto, warrants may be
9
exercised by delivery to the warrant agent of the certificate evidencing the warrants properly
completed and duly executed and of payment as provided in the prospectus supplement of the amount
required to purchase shares of common stock or shares of preferred stock purchasable upon such
exercise. The exercise price will be the price applicable on the date of payment in full, as set
forth in the prospectus supplement relating to the warrants. Upon receipt of the payment and the
certificate representing the warrants to be exercised properly completed and duly executed at the
office of the warrant agent or any other office indicated in the prospectus supplement, we will, as
soon as practicable, issue and deliver the shares of common stock or shares of preferred stock
purchasable upon such exercise. If fewer than all of the warrants represented by that certificate
are exercised, a new certificate will be issued for the remaining amount of warrants.
The description in the applicable prospectus supplement and other offering material of any
warrants we offer will not necessarily be complete and will be qualified in its entirety by
reference to the applicable warrant agreement, which will be filed with the SEC if we offer
warrants. For more information on how you can obtain copies of the applicable warrant agreement if
we offer warrants, see Documents Incorporated by Reference and Where You Can Find More
Information. We urge you to read the applicable warrant agreement and the applicable prospectus
supplement and any other offering material in their entirety.
PLAN OF DISTRIBUTION
We may sell the securities described in this prospectus on a continuous or delayed basis
directly to purchasers or through underwriters, broker-dealers or agents, who may receive
compensation in the form of discounts, concessions or commissions from us or the purchasers of the
securities. These discounts, concessions or commissions as to any particular underwriter,
broker-dealer or agent may be in excess of those customary in the types of transactions involved.
The securities may be sold from time to time in one or more transactions at fixed prices,
which may be changed from time to time, at prevailing market prices at the time of sale, at varying
prices determined at the time of sale or at negotiated prices. These sales may be effected in
transactions, which may involve crosses or block transactions:
|
|
|
on any national securities exchange or quotation service on which the securities may
be listed or quoted at the time of sale, including, as of the date of this prospectus,
the NASDAQ Global Select Market in the case of our common stock; |
|
|
|
|
in the over-the-counter market; |
|
|
|
|
in transactions otherwise than on these exchanges or services or in the
over-the-counter market; or |
|
|
|
|
through the writing of options, whether the options are listed on an options exchange
or otherwise. |
Each time that we use this prospectus to sell our securities, we will also provide a
prospectus supplement. For each series of securities, the applicable prospectus supplement will
set forth the terms of the offering including:
|
|
|
the public offering price; |
|
|
|
|
the name or names of any underwriters, dealers or agents; |
|
|
|
|
the purchase price of the securities; |
|
|
|
|
the proceeds from the sale of the securities to us; |
|
|
|
|
any underwriting discounts, agency fees, or other compensation payable to underwriters
or agents; |
|
|
|
|
any discounts or concessions allowed or reallowed or repaid to dealers; and |
|
|
|
|
the securities exchanges on which the securities will be listed, if any. |
If we use underwriters in the sale of securities, the securities will be acquired by the
underwriters for their own account. The underwriters may then resell the securities in one or more
transactions at a fixed public offering price or at varying prices determined at the time of sale
or thereafter. The securities may be either offered to the public through underwriting syndicates
represented by managing underwriters, or directly by underwriters. The obligations of the
underwriters to purchase the securities will be subject to certain conditions. The underwriters
will be
10
obligated to purchase all the securities offered if they purchase any securities. The public
offering price and any discounts or concessions allowed or re-allowed or paid to dealers may be
changed from time to time.
If we use dealers in the sale of securities, we will sell securities to such dealers as
principals. The dealers may then resell the securities to the public at varying prices to be
determined by such dealers at the time of resale. We may solicit offers to purchase the securities
directly, and we may sell the securities directly to institutional or other investors, who may be
deemed underwriters within the meaning of the Securities Act with respect to any resales of those
securities. The terms of these sales will be described in the applicable prospectus supplement. If
we use agents in the sale of securities, unless otherwise indicated in the prospectus supplement,
they will use their reasonable best efforts to solicit purchases for the period of their
appointment. Unless otherwise indicated in a prospectus supplement, if we sell directly, no
underwriters, dealers or agents would be involved. We will not make an offer of securities in any
jurisdiction that does not permit such an offer.
We may grant underwriters who participate in the distribution of securities an option to
purchase additional securities to cover overallotments, if any, in connection with the
distribution. Any underwriter may engage in overallotment, stabilizing transactions, short
covering transactions and penalty bids in accordance with SEC orders, rules and regulations and
applicable law. To the extent permitted by applicable law and SEC orders, rules and regulations,
an overallotment involves sales in excess of the offering size, which create a short position.
Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing
bids do not exceed a specified maximum. To the extent permitted by applicable law and SEC orders,
rules and regulations, short covering transactions involve purchases of the common stock in the
open market after the distribution is completed to cover short positions. Penalty bids permit the
underwriters to reclaim a selling concession from a dealer when the common stock originally sold by
the dealer is purchased in a covering transaction to cover short positions. Those activities may
cause the price of the common stock to be higher than it would otherwise be. If commenced, the
underwriters may discontinue any of the activities at any time.
Any underwriters who are qualified market makers on the NASDAQ Stock Market may engage in
passive market making transactions in the common stock on the NASDAQ Stock Market in accordance
with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before
the commencement of offers or sales of the common stock. Passive market makers must comply with
applicable volume and price limitations and must be identified as passive market makers. In
general a passive market maker must display its bid at a price not in excess of the highest
independent bid for such security; if all independent bids are lowered below the passive market
makers bid, however, the passive market makers bid must then be lowered when certain purchase
limits are exceeded.
Underwriters, dealers and agents that participate in any distribution of securities may be
deemed to be underwriters as defined in the Securities Act. Any discounts, commissions or profit
they receive when they resell the securities may be treated as underwriting discounts and
commissions under the Securities Act. Only underwriters named in the prospectus supplement are
underwriters of the securities offered in the prospectus supplement. We may have agreements with
underwriters, dealers and agents to indemnify them against certain civil liabilities, including
certain liabilities under the Securities Act, or to contribute with respect to payments that they
may be required to make.
We may authorize underwriters, dealers or agents to solicit offers from certain institutions
whereby the institution contractually agrees to purchase the securities from us on a future date at
a specific price. This type of contract may be made only with institutions that we specifically
approve. Such institutions could include banks, insurance companies, pension funds, investment
companies and educational and charitable institutions. The underwriters, dealers or agents will not
be responsible for the validity or performance of these contracts.
Each series of securities will be a new issue of securities. Our common stock is listed on
the NASDAQ Global Select Market. Unless otherwise specified in the applicable prospectus
supplement, the securities will not be listed on any exchange. It has not presently been
established whether the underwriters, if any, of the securities will make a market in the
securities. If the underwriters make a market in the securities, such market making may be
discontinued at any time without notice.
11
Agents, dealers and underwriters may be entitled to indemnification by us against certain
civil liabilities, including liabilities under the Securities Act, or to contribution with respect
to payments which the agents, dealers or underwriters may be required to make in respect thereof.
Agents, dealers or underwriters may be customers of, engage in transactions with, or perform
services for us and our subsidiaries in the ordinary course of business.
LEGAL MATTERS
The validity of the securities offered by this prospectus has been passed upon for us by
Mitchell, Williams, Selig, Gates & Woodyard, P.L.L.C., Little Rock, Arkansas. If legal matters in
connection with offerings made pursuant to this prospectus are passed upon by counsel for the
underwriters, dealers or agents, if any, such counsel will be named in the prospectus supplement
relating to such offering.
EXPERTS
BKD, LLP, independent registered public accounting firm, has audited our consolidated
financial statements as of December 31, 2008 and 2007, and for each of the three years in the
period ended December 31, 2008, included in our Annual Report on Form 10-K for the year ended
December 31, 2008, and the effectiveness of our internal control over financial reporting as of
December 31, 2008, as set forth in their reports, which are incorporated by reference in this
prospectus and elsewhere in the registration statement. Our financial statements are incorporated
by reference in reliance on BKD, LLPs reports, given on their authority as experts in accounting
and auditing.
12
HOME BANCSHARES, INC.
Common Stock
Preferred Stock
Rights
Warrants
PROSPECTUS
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 14. Other Expenses of Issuance and Distribution.
The following table sets forth the various expenses (other than underwriting discounts and
commissions) in connection with the issuance and distribution of the securities registered hereby.
Home BancShares will bear all of these expenses. All amounts are estimated except for the SEC
registration fee:
|
|
|
|
|
SEC registration fee |
|
$ |
14,260 |
|
Legal fees and expenses |
|
|
|
* |
Accounting fees and expenses |
|
|
|
* |
Miscellaneous fees and expenses |
|
|
|
* |
|
|
|
|
Total expenses |
|
$ |
|
* |
|
|
|
* |
|
Estimated expenses are not presently known. |
Item 15. Indemnification of Directors and Officers.
Our Articles of Incorporation and Bylaws authorize and require us to indemnify our directors,
officers, employees and agents to the full extent permitted by law. Section 4-27-850 of the
Arkansas Business Corporation Act of 1987 contains detailed and comprehensive provisions providing
for indemnification of directors and officers of Arkansas corporations against expenses, judgments,
fines and settlements in connection with litigation. Under Arkansas law, other than an action
brought by or in the right of Home BancShares, such indemnification is available if it is
determined that the proposed indemnitee acted in good faith and in a manner he or she reasonably
believed to be in or not opposed to the best interests of Home BancShares and, with respect to any
criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.
In actions brought by or in the right of Home BancShares, the Arkansas statute limits such
indemnification to expenses (including attorneys fees) actually and reasonably incurred in the
defense or settlement of such action if the indemnitee acted in good faith and in a manner he or
she reasonably believed to be in or not opposed to the best interests of Home BancShares. However,
no indemnification is allowed in actions brought by or in the right of Home BancShares with respect
to any claim, issue or matter as to which such person has been adjudged to be liable to us, unless
and only to the extent that the court determines upon application that, in view of all the
circumstances of the case, such person is fairly and reasonably entitled to indemnity for such
expenses as the court deems proper.
To the extent that the proposed indemnitee has been successful on the merits or otherwise in
defense of any action, suit or proceeding (or any claim, issue or matter therein), under Arkansas
law we must indemnify him or her against expenses (including attorneys fees) that he or she
actually and reasonably incurred in connection with such defense.
Our Articles of Incorporation also provide that no director shall be liable to us or our
shareholders for monetary damages for breach of fiduciary duty as a director to the fullest extent
permitted by the Arkansas Business Corporation Act.
Item 16. Exhibits.
The exhibits to this registration statement are listed on the exhibit index, which appears
elsewhere herein and is incorporated herein by reference.
Item 17. Undertakings.
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of
1933, as amended;
(ii) to reflect in the prospectus any facts or events arising after the effective date
of the registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or
decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of prospectus filed with
the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20 percent change in the maximum aggregate offering price set forth
in the Calculation of Registration Fee table in the effective registration statement; and
(iii) to include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to such
information in the registration statement;
Provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if
the registration statement is on Form S-3 or Form F-3 and the information required to be
included in a post-effective amendment by those paragraphs is contained in reports filed
with or furnished to the SEC by the registrant pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 that are incorporated by reference in the registration
statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is
part of the registration statement.
(2) That, for the purpose of determining any liability under the Securities Act of 1933,
as amended, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under the Securities Act of 1933, as
amended, to any purchaser:
(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed
to be part of the registration statement as of the date the filed prospectus was deemed part
of and included in the registration statement; and
(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or
(b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the
information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be
part of and included in the registration statement as of the earlier of the date such form
of prospectus is first used after effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As provided in Rule 430B, for
liability purposes of the issuer and any person that is at that date an underwriter, such
date shall be deemed to be a new effective date of the registration statement relating to
the securities in the registration statement to which the prospectus relates, and the
offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof. Provided, however, that no statement made in a registration statement or
prospectus that is part of the registration statement or made in a document incorporated or
deemed incorporated by reference into the registration statement or prospectus that is part
of the registration statement will, as to a purchaser with a time of contract of sale prior
to such effective date, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such effective date.
(5) That, for the purpose of determining liability of the registrant under the Securities
Act of 1933, as amended, to any purchaser in the initial distribution of the securities, the
undersigned registrant undertakes that in a primary offering of securities of the undersigned
registrant pursuant to this registration statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are offered or
sold to such purchaser by means of any of the following communications, the undersigned
registrant will be a seller to the purchaser and will be considered to offer or sell such
securities to such purchaser:
2
(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to
the offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of
the undersigned registrant or used or referred to by the undersigned registrant;
(iii) The portion of any other free writing prospectus relating to the offering
containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and
(iv) Any other communication that is an offer in the offering made by the undersigned
registrant to the purchaser.
(6) That, for purposes of determining any liability under the Securities Act of 1933, as
amended, the filing of the registrants annual report pursuant to Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934, as amended, (and, where applicable, each filing of an
employee benefit plans annual report pursuant to Section 15(d) of the Securities Exchange Act
of 1934, as amended) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
Insofar as indemnification for liabilities arising under the Securities Act of 1933, as
amended, may be permitted to directors, officers and controlling persons of the registrant
pursuant to the provisions described in Item 15 above, or otherwise, the registrant has been
advised that in the opinion of the SEC such indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the registrant of
expenses incurred or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, that the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act of 1933, as amended, and will be
governed by the final adjudication of such issue.
3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, Home BancShares, Inc.
certifies that it has reasonable grounds to believe that it meets all the requirements for filing
on Form S-3 and has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Conway, State of Arkansas, on January 14,
2010.
|
|
|
|
|
|
HOME BANCSHARES, INC.
|
|
|
|
|
|
|
|
By: |
/s/ C. Randall Sims
|
|
|
|
C. Randall Sims |
|
|
|
Chief Executive Officer |
|
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes
and appoints C. Randall Sims and Randy E. Mayor, and each of them, his true and lawful
attorneys-in-fact and agents, with full power of substitution, for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments (including post-effective
amendments) to this registration statement, and to file the same, with all exhibits thereto and all
documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and
agents full power and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and purposes as he might or
could do in person, hereby ratifying and confirming all that each said attorneys-in-fact and
agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration
statement has been signed by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Signature |
|
Title |
|
Date |
/s/ John W. Allison
John W. Allison
|
|
Chairman of the Board of Directors
|
|
January 13, 2010 |
|
|
|
|
|
/s/ C. Randall Sims
C. Randall Sims
|
|
Chief Executive Officer and
Director (Principal Executive
Officer)
|
|
January 14, 2010 |
|
|
|
|
|
/s/ Ron W. Strother
Ron W. Strother
|
|
President, Chief Operating
Officer
and Director
|
|
January 14, 2010 |
|
|
|
|
|
/s/ Randy E. Mayor
Randy E. Mayor
|
|
Chief Financial Officer,
Treasurer
and Director
(Principal
Financial
Officer and Principal
Accounting Officer)
|
|
January 14, 2010 |
|
|
|
|
|
/s/ Robert H. Adcock, Jr.
Robert H. Adcock, Jr.
|
|
Vice Chairman of the Board and
Director
|
|
January 14, 2010 |
|
|
|
|
|
/s/ Richard H. Ashley
|
|
Director
|
|
January 12, 2010 |
|
|
|
|
|
Richard H. Ashley |
|
|
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date |
/s/ Dale A. Bruns
|
|
Director
|
|
January 14, 2010 |
|
|
|
|
|
Dale A. Bruns |
|
|
|
|
|
|
|
|
|
/s/ Richard A. Buckheim
|
|
Director
|
|
January 12, 2010 |
|
|
|
|
|
Richard A. Buckheim |
|
|
|
|
|
|
|
|
|
/s/ Jack E. Engelkes
|
|
Director
|
|
January 14, 2010 |
|
|
|
|
|
Jack E. Engelkes |
|
|
|
|
|
|
|
|
|
/s/ James G. Hinkle
|
|
Director
|
|
January 14, 2010 |
|
|
|
|
|
James G. Hinkle |
|
|
|
|
|
|
|
|
|
/s/ Alex R. Lieblong
|
|
Director
|
|
January 14, 2010 |
|
|
|
|
|
Alex R. Lieblong |
|
|
|
|
|
|
|
|
|
/s/ William G. Thompson
|
|
Director
|
|
January 12, 2010 |
|
|
|
|
|
William G. Thompson |
|
|
|
|
5
EXHIBIT INDEX
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
4.1
|
|
|
|
Restated Articles of Incorporation of Home BancShares, Inc. (incorporated by reference to
Exhibit 3.1 of Home BancSharess registration statement on Form S-1 (File No.
333-132427), as amended) |
|
|
|
|
|
4.2
|
|
|
|
Amendment to the Restated Articles of Incorporation of Home BancShares, Inc.
(incorporated by reference to Exhibit 3.2 of Home BancSharess registration statement on
Form S-1 (File No. 333-132427), as amended) |
|
|
|
|
|
4.3
|
|
|
|
Second Amendment to the Restated Articles of Incorporation of Home BancShares, Inc.
(incorporated by reference to Exhibit 3.3 of Home BancSharess registration statement on
Form S-1 (File No. 333-132427), as amended) |
|
|
|
|
|
4.4
|
|
|
|
Third Amendment to the Restated Articles of Incorporation of Home BancShares, Inc.
(incorporated by reference to Exhibit 3.4 of Home BancSharess registration statement on
Form S-1 (File No. 333-132427), as amended) |
|
|
|
|
|
4.5
|
|
|
|
Fourth Amendment to the Restated Articles of Incorporation of Home BancShares, Inc.
(incorporated by reference to Exhibit 3.1 of Home BancSharess Quarterly Report on Form
10-Q for the quarter ended June 30, 2007, filed on August 8, 2007) |
|
|
|
|
|
4.6
|
|
|
|
Fifth Amendment to the Restated Articles of Incorporation of Home BancShares, Inc.
(incorporated by reference to Exhibit 4.6 of Home BancSharess registration statement on
Form S-3 (File No. 333-157165)) |
|
|
|
|
|
4.7
|
|
|
|
Certificate of Designations of Fixed Rate Cumulative Perpetual Preferred Stock, Series A,
filed with the Secretary of State of the State of Arkansas on January 14, 2009
(incorporated by reference to Exhibit 3.1 of Home BancSharess Current Report on Form
8-K, filed on January 21, 2009) |
|
|
|
|
|
4.8
|
|
|
|
Restated Bylaws of Home BancShares, Inc. (incorporated by reference to Exhibit 3.5 of
Home BancSharess registration statement on Form S-1 (File No. 333-132427), as amended) |
|
|
|
|
|
4.9
|
|
|
|
Letter Agreement, dated January 16, 2009, including the Securities Purchase Agreement
Standard Terms incorporated by reference therein, between the Company and the Treasury
(incorporated by reference to Exhibit 10.1 of Home BancSharess Current Report on Form
8-K, filed on January 21, 2009) |
|
|
|
|
|
4.10
|
|
|
|
Warrant to purchase up to 288,129 shares of Common Stock, issued on January 16, 2009
(incorporated by reference to Exhibit 4.1 of Home BancSharess Current Report on Form
8-K, filed on January 21, 2009) (Pursuant to the terms of the Warrant, the share amount of the Warrant has been reduced, as of November 3, 2009, to
144,065 shares.) |
|
|
|
|
|
4.11
|
|
|
|
Specimen Stock Certificate representing Home BancShares, Inc. Common Stock (incorporated
by reference to Exhibit 4.6 of Home BancSharess registration statement on Form S-1 (File
No. 333-132427), as amended) |
|
|
|
|
|
4.12*
|
|
|
|
Form of Certificate of Designations with respect to any series of preferred stock issued
hereunder |
|
|
|
|
|
4.13*
|
|
|
|
Form of Preferred Stock Certificate |
|
|
|
|
|
4.14*
|
|
|
|
Form of Rights Agreement |
|
|
|
|
|
4.15*
|
|
|
|
Form of Warrant Agreement, including form of Warrant Certificate |
|
|
|
|
|
5.1
|
|
|
|
Opinion of Mitchell, Williams, Selig, Gates & Woodyard, P.L.L.C. |
|
|
|
|
|
12.1
|
|
|
|
Computation of Ratio of Earnings to Fixed Charges and Preferred Share Dividends |
|
|
|
|
|
15.1
|
|
|
|
Awareness Letter from BKD, LLP regarding unaudited interim financial information |
6
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description |
23.1
|
|
|
|
Consent of BKD, LLP |
|
|
|
|
|
23.2
|
|
|
|
Consent of Mitchell, Williams, Selig, Gates & Woodyard, P.L.L.C. (included in Exhibit 5.1) |
|
|
|
|
|
24.1
|
|
|
|
Power of Attorney (on signature page) |
|
|
|
* |
|
To be filed by a post-effective amendment to this registration statement or as an exhibit to a
Current Report on Form 8-K and incorporated by reference herein. |
7